• 1
    Poulsen, A. G., Aaby, P., Larsen, O., Jensen, H., Naucler, A., Lisse, I. M., Christiansen, C. B. et al., 9-year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 1997 349: 911914.
  • 2
    Schim van der Loeff, M. F., Jaffar, S., Aveika, A. A., Sabally, S., Corrah, T., Harding, E., Alabi, A. et al., Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. Aids 2002 16: 17751783.
  • 3
    Ariyoshi, K., Jaffar, S., Alabi, A. S., Berry, N., Schim van der Loeff, M., Sabally, S., N'Gom, P. T. et al., Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. Aids 2000 14: 339344.
  • 4
    Berry, N., Jaffar, S., Schim van der Loeff, M., Ariyoshi, K., Harding, E., N'Gom, P. T., Dias, F. et al., Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res. Hum. Retroviruses 2002 18: 11671173.
  • 5
    Ariyoshi, K., Berry, N., Wilkins, A., Ricard, D., Aaby, P., Naucler, A., Ngom, P. T. et al., A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J. Infect. Dis. 1996 173: 245248.
  • 6
    Berry, N., Ariyoshi, K., Jobe, O., Ngum, P. T., Corrah, T., Wilkins, A., Whittle, H. and Tedder, R., HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res. Hum. Retroviruses 1994 10: 10311037.
  • 7
    Sarr, A. D., Popper, S., Thior, I., Hamel, D. J., Sankale, J. L., Siby, T., Marlink, R. et al., Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. J. Hum. Virol. 1999 2: 4551.
  • 8
    Whittle, H. C., Ariyoshi, K. and Rowland-Jones, S., HIV-2 and T cell recognition. Curr. Opin. Immunol. 1998 10: 382387.
  • 9
    Gotch, F., McAdam, S. N., Allsopp, C. E., Gallimore, A., Elvin, J., Kieny, M. P., Hill, A. V. et al., Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 1993 151: 33613369.
  • 10
    Bertoletti, A., Cham, F., McAdam, S., Rostron, T., Rowland-Jones, S., Sabally, S., Corrah, T. et al., Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J. Virol. 1998 72: 24392448.
  • 11
    Gillespie, G. M., Pinheiro, S., Sayeid-Al-Jamee, M., Alabi, A., Kaye, S., Sabally, S., Sarge-Njie, R. et al., CD8(+) T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Eur. J. Immunol. 2005 35: 14451453.
  • 12
    Jaye, A., Sarge-Njie, R., Schim van der Loeff, M., Todd, J., Alabi, A., Sabally, S., Corrah, T. and Whittle, H., No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. J. Infect. Dis. 2004 189: 498505.
  • 13
    Zheng, N. N., Kiviat, N. B., Sow, P. S., Hawes, S. E., Wilson, A., Diallo-Agne, H., Critchlow, C. W. et al., Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J. Virol. 2004 78: 1393413942.
  • 14
    Duvall, M. G., Jaye, A., Dong, T., Brenchley, J. M., Alabi, A. S., Jeffries, D. J., van der Sande, M. et al., Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 2006 176: 69736981.
  • 15
    Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S. and Shearer, G. M., Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 1989 84: 18921899.
  • 16
    Musey, L. K., Krieger, J. N., Hughes, J. P., Schacker, T. W., Corey, L. and McElrath, M. J., Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J. Infect. Dis. 1999 180: 278284.
  • 17
    Younes, S. A., Yassine-Diab, B., Dumont, A. R., Boulassel, M. R., Grossman, Z., Routy, J. P. and Sekaly, R. P., HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J. Exp. Med. 2003 198: 19091922.
  • 18
    Pitcher, C. J., Quittner, C., Peterson, D. M., Connors, M., Koup, R. A., Maino, V. C. and Picker, L. J., HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 1999 5: 518525.
  • 19
    Iyasere, C., Tilton, J. C., Johnson, A. J., Younes, S., Yassine-Diab, B., Sekaly, R. P., Kwok, W. W. et al., Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 2003 77: 1090010909.
  • 20
    Pinto, L. A., Covas, M. J. and Victorino, R. M., T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients. Aids 1993 7: 13891391.
  • 21
    Pinto, L. A., Covas, M. J. and Victorino, R. M., T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals. J. Med. Virol. 1995 47: 139144.
  • 22
    Sousa, A. E., Chaves, A. F., Loureiro, A. and Victorino, R. M., Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J. Infect. Dis. 2001 184: 552559.
  • 23
    Betts, M. R., Nason, M. C., West, S. M., De Rosa, S. C., Migueles, S. A., Abraham, J., Lederman, M. M. et al., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006 107: 47814789.
  • 24
    De Rosa, S. C., Lu, F. X., Yu, J., Perfetto, S. P., Falloon, J., Moser, S., Evans, T. G. et al., Vaccination in humans generates broad T cell cytokine responses. J. Immunol. 2004 173: 53725380.
  • 25
    Betts, M. R., Exley, B., Price, D. A., Bansal, A., Camacho, Z. T., Teaberry, V., West, S. M. et al., Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc. Natl. Acad. Sci. USA 2005 102: 45124517.
  • 26
    Precopio, M. L., Betts, M. R., Parrino, J., Price, D. A., Gostick, E., Ambrozak, D. R., Asher, T. E. et al., Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T Cell responses. J. Exp. Med. 2007 204: 14051416.
  • 27
    Chattopadhyay, P. K., Price, D. A., Harper, T. F., Betts, M. R., Yu, J., Gostick, E., Perfetto, S. P. et al., Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat. Med. 2006 12: 972977.
  • 28
    Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401: 708712.
  • 29
    Wang, E. C., Moss, P. A., Frodsham, P., Bell, J. I. and Borysiewicz, L. K., CD8highCD57+ T lymphocytes in normal healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 1995 155: 50465056.
  • 30
    Wang, E. C., Taylor-Wiedeman, J., Perera, P., Fisher, J. and Borysiewicz, L. K., Subsets of CD8+, CD57+ cells in normal healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin. Exp. Immunol. 1993 94: 297305.
  • 31
    Miles, D. J., van der Sande, M., Jeffries, D., Kaye, S., Ismaili, J., Ojuola, O., Sanneh, M. et al., Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J. Virol. 2007 81: 57665776.
  • 32
    Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P. et al., HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002 417: 9598.
  • 33
    Henkart, P., Henkart, M., Millard, P., Frederikse, P., Bluestone, J., Blumenthal, R., Yue, C. and Reynolds, C., The role of cytoplasmic granules in cytotoxicity by large granular lymphocytes and cytotoxic T lymphocytes. Adv. Exp. Med. Biol. 1985 184: 121138.
  • 34
    Henkart, P. A., Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 1985 3: 3158.
  • 35
    Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M. and Koup, R. A., Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003 281: 6578.
  • 36
    Rubio, V., Stuge, T. B., Singh, N., Betts, M. R., Weber, J. S., Roederer, M. and Lee, P. P., Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 2003 9: 13771382.
  • 37
    Zaunders, J. J., Dyer, W. B., Wang, B., Munier, M. L., Miranda-Saksena, M., Newton, R., Moore, J. et al., Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood 2004 103: 22382247.
  • 38
    Appay, V., Zaunders, J. J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P. et al., Characterization of CD4(+) CTLs ex vivo. J. Immunol. 2002 168: 59545958.
  • 39
    Casazza, J. P., Betts, M. R., Price, D. A., Precopio, M. L., Ruff, L. E., Brenchley, J. M., Hill, B. J. et al., Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med. 2006 203: 28652877.
  • 40
    Harari, A., Vallelian, F., Meylan, P. R. and Pantaleo, G., Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 2005 174: 10371045.
  • 41
    Beveridge, N. E., Price, D. A., Casazza, J. P., Pathan, A. A., Sander, C. R., Asher, T. E., Ambrozak, D. R. et al., Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4(+) memory T lymphocyte populations. Eur. J. Immunol. 2007 37: 30893100.
  • 42
    Harari, A., Petitpierre, S., Vallelian, F. and Pantaleo, G., Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004 103: 966972.
  • 43
    Boaz, M. J., Waters, A., Murad, S., Easterbrook, P. J. and Vyakarnam, A., Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 2002 169: 63766385.
  • 44
    Emu, B., Sinclair, E., Favre, D., Moretto, W. J., Hsue, P., Hoh, R., Martin, J. N. et al., Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J. Virol. 2005 79: 1416914178.
  • 45
    Deeks, S. G. and Walker, B. D., Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007 27: 406416.
  • 46
    Zimmerli, S. C., Harari, A., Cellerai, C., Vallelian, F., Bart, P. A. and Pantaleo, G., HIV-1-specific IFN-{gamma}/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. USA 2005 102: 72397244.
  • 47
    Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W., Davey, D. F., Flynn, B. J., Hoff, S. T. et al., Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 2007 13: 843850.
  • 48
    Berry, N., Ariyoshi, K., Jaffar, S., Sabally, S., Corrah, T., Tedder, R. and Whittle, H., Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1998 1: 457468.
  • 49
    Cham, F., Heyndrickx, L., Janssens, W., Van der Auwera, G., Vereecken, K., De Houwer, K., Coppens, S. et al., Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res. Hum. Retroviruses 2000 16: 19151919.
  • 50
    Andersson, S., Norrgren, H., Dias, F., Biberfeld, G. and Albert, J., Molecular characterization of human immunodeficiency virus (HIV)-1 and –2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology 1999 262: 312320.
  • 51
    Perfetto, S. P., Chattopadhyay, P. K., Lamoreaux, L., Nguyen, R., Ambrozak, D., Koup, R. A. and Roederer, M., Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J. Immunol. Methods 2006 313: 199208.